Last reviewed · How we verify
NCT03248999: R'EHPAD
Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.
NA trial testing rectal swab in Drug Resistance, Bacterial in 264 participants. Completed in 26 June 2018.
26 June 2018
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Besancon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 264 |
| Start date | 20 November 2017 |
| Primary completion | 26 June 2018 |
| Estimated completion | 26 June 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- rectal swab — full drug profile →
Conditions studied
- Drug Resistance, Bacterial — all drugs for Drug Resistance, Bacterial →
Sponsor
Centre Hospitalier Universitaire de Besancon
Who can join
18 and older, any sex, with Drug Resistance, Bacterial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates individual and collective factors of ESBL and CRE carriage in nursing homes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03248999
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of rectal swab
Trials testing the same drug.
- NCT04937361 — Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network · unknown
- NCT04355533 — Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 · NA · completed
- NCT02928367 — The Effect of Leukocyte Dna mEthylation and micRoBIOME Diversity on Host Defense Mechanisms During Community-acquired Pn · unknown
Other recruiting trials for Drug Resistance, Bacterial
Currently open trials in the same condition.
- NCT07094984 — Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract · NA · recruiting
- NCT07052604 — Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients · recruiting
Other Centre Hospitalier Universitaire de Besancon trials
Trials by the same sponsor.
- NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
- NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
- NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
- NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
- NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03248999 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
- Last refreshed: 6 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03248999.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing